David L. Paterson

Molecular Medicine · 2001–2020

A researcher in the Science corpus: 22 papers; trusts 4 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

• Molecular Medicine — 115 citations into it; #46 of 296 by trust here, #15 by citations
• Molecular Biology — 57 citations into it; #8,604 of 17,773 by trust here, #13,563 by citations
• Endocrinology — 46 citations into it; #50 of 250 by trust here, #44 by citations
• Applied Microbiology and Biotechnology — 25 citations into it

Whom David L. Paterson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. L. Poirel
2. P. Bradford
3. P. Nordmann
4. G. Jacoby

Who trusts David L. Paterson overall

1. C. Giske
2. Amy Mathers
3. Zeinab Breijyeh
4. William R. Miller
5. A. Carattoli
6. J. Pitout

Papers from David L. Paterson's perspective

Ordered by how strongly the researchers David L. Paterson trusts endorse each paper. Same corpus, a different order for every researcher.

1. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. (FEMS Microbiology Letters)
2. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
3. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. (Clinical Microbiology and Infection)
4. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii (PLoS Genetics)
5. The worldwide emergence of plasmid-mediated quinolone resistance. (Lancet. Infectious Diseases (Print))
6. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. (Lancet. Infectious Diseases (Print))
7. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. (Clinical Infectious Diseases)
8. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
9. Echinocandin antifungal drugs. (The Lancet)
10. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (Clinical Infectious Diseases)

Their papers

• Acinetobacter baumannii: Emergence of a Successful Pathogen (2008) — 3,455 citations
• Antimicrobial Resistance in ESKAPE Pathogens (2020) — 1,546 citations
• Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial (2018) — 675 citations
• Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) — 4,785 citations
• Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases (2013) — 1,554 citations
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (2012) — 13,127 citations
• Predictors of Mortality in Staphylococcus aureus Bacteremia (2012) — 858 citations
• Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. (2011) — 759 citations
• Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients (2011) — 691 citations
• Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (2010) — 2,893 citations
• Critical care services and 2009 H1N1 influenza in Australia and New Zealand. (2009) — 1,014 citations
• Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (2007) — 2,493 citations
• Resistance in gram-negative bacteria: enterobacteriaceae. (2006) — 1,005 citations
• Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (2006) — 1,327 citations
• A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use (2005) — 667 citations
• Aspergillus Infections in Transplant Recipients (2005) — 596 citations
• International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections (2004) — 673 citations
• Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (2004) — 604 citations
• Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. (2002) — 694 citations
• Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns (2002) — 596 citations